Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
RSC Advances
|
May 13, 2022
Synthesis of coaxial carbon@NiMoO<sub>4</sub> composite nanofibers for supercapacitor electrodes
Changqing Teng, Xuehui Gao, Ning Zhang, et al.
Frontiers in Endocrinology
|
April 5, 2024
Develop prediction model to help forecast advanced prostate cancer patients' prognosis after surgery using neural network
Shanshan Li, Siyu Cai, Jinghong Huang, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
September 29, 2025
<i>Mycobacterium tuberculosis</i> infection status and associated factors among household close contacts of rifampicin-resistant pulmonary tuberculosis patients: A single-center cross-sectional study
Zhengyu Shi, Juan Peng, Xiu Li, et al.
Scientific Reports
|
July 28, 2024
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
Qing Chen, Tao Huang, Liping Zou, et al.
Infection and Drug Resistance
|
September 2, 2024
Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in China
Liping Zou, Wanli Kang, Chunhui Guo, et al.
Scientific Reports
|
November 5, 2025
Prevalence of comorbidities and their impact on prognosis among patients with rifampicin-resistant tuberculosis: a multicenter retrospective cohort study in China
Liping Zou, Zhili Li, Qing Pan, et al.
BMC Infectious Diseases
|
September 1, 2025
Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China
Huicong Liu, Liping Zou, JiaJia Yu, et al.
Annals of Medicine
|
February 23, 2021
Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
Chuan Li, Fengming Luo, Chengwu Liu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
RSC Advances
|
May 13, 2022
Synthesis of coaxial carbon@NiMoO<sub>4</sub> composite nanofibers for supercapacitor electrodes
Changqing Teng, Xuehui Gao, Ning Zhang, et al.
Frontiers in Endocrinology
|
April 5, 2024
Develop prediction model to help forecast advanced prostate cancer patients' prognosis after surgery using neural network
Shanshan Li, Siyu Cai, Jinghong Huang, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
September 29, 2025
<i>Mycobacterium tuberculosis</i> infection status and associated factors among household close contacts of rifampicin-resistant pulmonary tuberculosis patients: A single-center cross-sectional study
Zhengyu Shi, Juan Peng, Xiu Li, et al.
Scientific Reports
|
July 28, 2024
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
Qing Chen, Tao Huang, Liping Zou, et al.
Infection and Drug Resistance
|
September 2, 2024
Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in China
Liping Zou, Wanli Kang, Chunhui Guo, et al.
Scientific Reports
|
November 5, 2025
Prevalence of comorbidities and their impact on prognosis among patients with rifampicin-resistant tuberculosis: a multicenter retrospective cohort study in China
Liping Zou, Zhili Li, Qing Pan, et al.
BMC Infectious Diseases
|
September 1, 2025
Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China
Huicong Liu, Liping Zou, JiaJia Yu, et al.
Annals of Medicine
|
February 23, 2021
Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
Chuan Li, Fengming Luo, Chengwu Liu, et al.
Page
of 2